2023-07-13
On Thursday, July 13, 2023, Mark Cuban’s Price Plus Drug Firm introduced it is going to provide a 30-day provide of the latest SGLT-2 inhibitor available on the market, Brenzavvy, for treating sort 2 diabetes. A 30-day provide will value $47.85 plus delivery.
Price Plus Medication has no membership charges, and insurance coverage just isn’t required to fill a prescription for Brenzavvy at this value.
SGLT-2s are also referred to as sodium-glucose cotransporters or gliflozins. This group of oral drugs for managing sort 2 diabetes is comparatively new, as canagliflozin (Invokana), one other SGLT-2 medicine, was first authorised in 2013. SGLT-2s assist deal with diabetes by lowering renal glucose reabsorption and rising its urinary elimination, reducing blood glucose concentrations.
These drugs stop your kidneys from reabsorbing glucose concentrations into your bloodstream and assist your physique remove the surplus via urine.
In response to the Endocrinology Community, SGLT-2s decrease blood glucose ranges in two methods:
Decreasing the quantity of glucose the kidneys soak up to excrete via urine.
Decreasing the quantity of glucose within the bloodstream.
Price Plus Medication CEO and co-founder Dr. Alex Oshmyanksy shared that the corporate prioritizes merchandise for individuals with diabetes like SGLT-2s. SGLT-2s are clinically proven to have significant advantages for individuals with sort 2 diabetes, together with lowering the danger of different comorbid situations.
“Sadly, People with diabetes have suffered from artificially inflated drug and provide costs for a lot too lengthy,” Dr. Oshmyansky acknowledged. “As a diabetic myself, I’ve skilled this challenge first-hand, so including extra merchandise for individuals with diabetes at affordable costs is a high precedence for us.”
With Price Plus Medication providing drugs like Brenzavvy and Invokana at extra reasonably priced costs, entry to SGLT-2 medicines can enhance and positively impression over 30 million People residing with sort 2 diabetes immediately.